Skip to content

EQA Program

Our external quality assessment (EQA) program is aimed at medical laboratories and point-of-care testing sites. The program includes more than 250 clinically relevant external quality assessment schemes and it is compliant with ISO 15189 standard requirements.

Changes in the 2025 program

New schemes and products

  • 5850 Brucella antibodies
  • 5241 Bordetella pertussis/parapertussis, nucleic acid detection
  • 5687 HBsAg and HCVAb POCT
  • 5251 Interferon Gamma Release Assay (IGRA) for Mycobacterium tuberculosis - whole blood sample
  • 5686 Norovirus, antigen detection
  • 2755 Holotranscobalamin (HoloTC) and Methylmalonic Acid

Planned pilot schemes

Pilot schemes are EQA schemes under our product development.

All changes are listed in the Product Catalogue on page 5.

Subscription for 2025 will open on 2 September 2024

Please subscribe to the 2025 EQA programs before the end of November 2024 to ensure your participation in all needed EQA rounds. You can renew your subscription by contacting our local partner in your country. Direct customers can renew their subscriptions on LabScala starting on 2 September 2024. If you need more information, please contact our customer service: info@aurevia.com.

LQ_web news_EQA_EQA program 2025_1280x720

Sales and Customer Service

Juha Wahlstedt
Juha Wahlstedt
Sales Director
+358 50 327 5338
Jukka Korhonen
Jukka Korhonen
Key Account Manager
+358 50 540 9351
Minna Kankainen
Minna Kankainen
Customer Service Manager
+358 45 131 1682

Explore our services

LQ_web news_EQA_EQA program 2025_1280x720

EQA Product Catalogue

Our external quality assessment service program includes more than 250 quality assessment schemes, covering all specialities of laboratory medicine. Furthermore, the program includes an extensive selection of services designed for medical laboratories and point-of-care testing sites.

golden-wave-pattern-with-word-gold-it (1)

Integrated EQA Service

Integrated EQA service is a completely new approach to external quality assessment. New programs integrate pre- and post-analytical EQA schemes into traditional analytical EQA providing support according to the ISO 15189 standard requirements.
doctor-performing-medical-research-lab (1)

New EQA Schemes

We actively follow the development of laboratory medicine as we want to produce clinically relevant EQA schemes to serve clinical laboratories and point-of-care sites. We launch new pilot studies on a regular basis and aim to increase our EQA portfolio with 5-10 new EQA schemes every year.
Web Banners_600x350-08

Digital External Quality Assessment Programs

Our digital EQA product line provides an advanced approach to external quality assessment. Digital EQA programs or virtual EQA programs use digital images, videos, virtual microscopy technology, and questionnaires as EQA samples.

Latest news

QAdvis and Scandinavian CRO join Aurevia to strengthen clinical research and regulatory expertise

Scandinavian CRO (SCRO) and QAdvis will now operate under the name of Aurevia.

Meet us at ESCMID 2025 in Vienna

We will be at the ESCMID 11-15 April 2025 in Vienna, Austria.

Aurevia appoints Jonna Pelanti as the new Head of EQA business area

We are delighted to announce the appointment of the new Head of the EQA business area Jonna Pelanti.
Meet us at BioMedica in Dublin on 18-20 March.

Meet us at BioMedica in Dublin

Meet us at the BioMedica exhibition at booth A18!

Aurevia appoints Ulrika Hammarström as the new Head of CRO business area

We are delighted to announce the appointment of the new Head of the CRO business area Ulrika Hammarström.